2009
DOI: 10.4161/rna.6.2.7727
|View full text |Cite
|
Sign up to set email alerts
|

Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression

Abstract: Riboswitches in messenger RNAs carry receptor domains called aptamers that can bind to metabolites and control expression of associated genes. The Gram-positive bacterium Bacillus subtilis has two representatives of a class of riboswitches that bind flavin mononucleotide (FMN). These riboswitches control genes responsible for the biosynthesis and transport of riboflavin, a precursor of FMN. We found that roseoflavin, a chemical analog of FMN and riboflavin that has antimicrobial activity, can directly bind to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

9
184
0
1

Year Published

2010
2010
2024
2024

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 216 publications
(194 citation statements)
references
References 39 publications
9
184
0
1
Order By: Relevance
“…The secondary structure of this sequence, which depends on the presence or absence of the ligand, directs the folding of the rest of the expression platform into two mutually exclusive forms that represent the on and off states of the mRNA (Garst et al 2011;Batey 2012;Serganov and Patel 2012). The active role that riboswitches play in regulating bacterial transcription makes them enticing targets for development of novel antibiotics, and several drug-like small molecules have been found to bind to riboswitches and slow cell growth (Sudarsan et al 2005;Blount et al 2007; Lee et al 2009). …”
Section: Introductionmentioning
confidence: 99%
“…The secondary structure of this sequence, which depends on the presence or absence of the ligand, directs the folding of the rest of the expression platform into two mutually exclusive forms that represent the on and off states of the mRNA (Garst et al 2011;Batey 2012;Serganov and Patel 2012). The active role that riboswitches play in regulating bacterial transcription makes them enticing targets for development of novel antibiotics, and several drug-like small molecules have been found to bind to riboswitches and slow cell growth (Sudarsan et al 2005;Blount et al 2007; Lee et al 2009). …”
Section: Introductionmentioning
confidence: 99%
“…Riboswitches appear capable of manipulating the expression of genes related to metabolite biosynthesis without direct interaction with proteins. Moreover, riboswitches have been suggested as potential drug targets (Blount and Breaker 2006;Blount et al 2007;Kim et al 2009;Lee et al 2009;Cressina et al 2011;Daldrop et al 2011;Deigan and Ferré-D'Amaré 2011;Maciagiewicz et al 2011) and for a number of potential engineering applications (Wieland and Hartig 2008;Link and Breaker 2009;Topp and Gallivan 2010), highlighting the importance of understanding mechanisms for specificity and recognition of riboswitches by small molecule ligands Haller et al 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Although present in all domains of life, they are prominent in bacteria where they typically reside in the 5′-leader sequences of mRNA (2). Broad interest in riboswitches originates from the discovery that they can be targeted by antimicrobials (3)(4)(5), and the observation that they use complex scaffolds to achieve gene regulation without the need for protein partners. In the latter respect, riboswitches typically exhibit bipartite sequence organization comprising a conserved aptamer linked to a downstream expression platform (2).…”
mentioning
confidence: 99%